- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 871272, 10 pages
Role of Pigment Epithelium-Derived Factor in Stem/Progenitor Cell-Associated Neovascularization
1Department of Neurosurgery, School of Medicine, Chung-Shan Medical University and Hospital, Taichung 402, Taiwan
2Department of Anatomy and Cell Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan
3Graduate Institutes of Integrated Medicine and Acupuncture Science, College of Chinese Medicine, China Medical University, Taichung 404, Taiwan
4Departments of Urology, Obstetrics and Gynecology, and Medical Research, China Medical University Hospital, Taichung 404, Taiwan
5Department of Anesthesiology, Tungs’ Taichung Metroharbor Hospital, Taichung 433, Taiwan
6Department of Fragrance and Cosmetic Science, and Department of Respiratory Therapy, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
7School of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei 112, Taiwan
Received 12 December 2011; Accepted 26 March 2012
Academic Editor: Crispin Dass
Copyright © 2012 Jung-Tung Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. Tombran-Tink and L. V. Johnson, “Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells,” Investigative Ophthalmology and Visual Science, vol. 30, no. 8, pp. 1700–1707, 1989.
- F. R. Steele, G. J. Chader, L. V. Johnson, and J. Tombran-Tink, “Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 4, pp. 1526–1530, 1993.
- E. T. H. Ek, C. R. Dass, and P. F. M. Choong, “PEDF: a potential molecular therapeutic target with multiple anti-cancer activities,” Trends in Molecular Medicine, vol. 12, no. 10, pp. 497–502, 2006.
- K. Rychli, K. Huber, and J. Wojta, “Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease,” Expert Opinion on Therapeutic Targets, vol. 13, no. 11, pp. 1295–1302, 2009.
- J. Tombran-Tink, G. G. Chader, and L. V. Johnson, “PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity,” Experimental Eye Research, vol. 53, no. 3, pp. 411–414, 1991.
- M. M. Bilak, A. M. Corse, S. R. Bilak, M. Lehar, J. Tombran-Tink, and R. W. Kuncl, “Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration,” Journal of Neuropathology and Experimental Neurology, vol. 58, no. 7, pp. 719–728, 1999.
- M. A. DeCoster, E. Schabelman, J. Tombran-Tink, et al., “Neuroprotection by pigment epithelial-derived factor against glutamate toxicity in developing primary hippocampal neurons,” Journal of Neuroscience Research, vol. 56, no. 6, pp. 604–610, 1999.
- T. Falk, S. Zhang, and S. J. Sherman, “Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease,” Neuroscience Letters, vol. 458, no. 2, pp. 49–52, 2009.
- T. Sanagi, T. Yabe, and H. Yamada, “Adenoviral gene delivery of pigment epithelium-derived factor protects striatal neurons from quinolinic acid-induced excitotoxicity,” Journal of Neuropathology and Experimental Neurology, vol. 69, no. 3, pp. 224–233, 2010.
- D. W. Dawson, O. V. Volpert, P. Gillis et al., “Pigment epithelium-derived factor: a potent inhibitor of angiogenesis,” Science, vol. 285, no. 5425, pp. 245–248, 1999.
- E. M. Levy, M. P. Roberti, and J. Mordoh, “Natural killer cells in human cancer: from biological functions to clinical applications,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 676198, 11 pages, 2011.
- S. X. Zhang, J. J. Wang, G. Gao, C. Shao, R. Mott, and J. X. Ma, “Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor,” FASEB Journal, vol. 20, no. 2, pp. 323–325, 2006.
- S. I. Yamagishi, K. Nakamura, S. Ueda, S. Kato, and T. Imaizumi, “Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF,” Cell and Tissue Research, vol. 320, no. 3, pp. 437–445, 2005.
- S. H. Wang, S. J. Lin, Y. H. Chen et al., “Late outgrowth endothelial cells derived from wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 6, pp. 816–822, 2009.
- J. Tombran-Tink, “PEDF in angiogenic eye diseases,” Current Molecular Medicine, vol. 10, no. 3, pp. 267–278, 2010.
- H. Funatsu, H. Yamashita, S. Nakamura et al., “Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema,” Ophthalmology, vol. 113, no. 2, pp. 294–301, 2006.
- J. A. Doll, V. M. Stellmach, N. P. Bouck et al., “Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas,” Nature Medicine, vol. 9, no. 6, pp. 774–780, 2003.
- R. Hase, M. Miyamoto, H. Uehara et al., “Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice,” Clinical Cancer Research, vol. 11, no. 24, pp. 8737–8744, 2005.
- S. Filleur, K. Volz, T. Nelius et al., “Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer,” Cancer Research, vol. 65, no. 12, pp. 5144–5152, 2005.
- R. Abe, Y. Fujita, S. I. Yamagishi, and H. Shimizu, “Pigment epithelium-derived factor prevents melanoma growth via angiogenesis inhibition,” Current Pharmaceutical Design, vol. 14, no. 36, pp. 3802–3809, 2008.
- A. L. George, P. Bangalore-Prakash, S. Rajoria et al., “Endothelial progenitor cell biology in disease and tissue regeneration,” Journal of Hematology and Oncology, vol. 4, article 24, 2011.
- M. Matthias, N. David, and N. Josef, “From bench to bedside: what physicians need to know about endothelial progenitor cells,” American Journal of Medicine, vol. 124, no. 6, pp. 489–497, 2011.
- A. J. Roks, K. Rodgers, and T. Walther, “Effects of the renin angiotensin system on vasculogenesis-related progenitor cells,” Current Opinion in Pharmacology, vol. 11, no. 2, pp. 162–174, 2011.
- S. Fang and P. Salven, “Stem cells in tumor angiogenesis,” Journal of Molecular and Cellular Cardiology, vol. 50, no. 2, pp. 290–295, 2011.
- R. Longeras, K. Farjo, M. Ihnat, et al., “A PEDF-derived peptide inhibits retinal neovascularization and blocks mobilization of bone marrow-derived endothelial progenitor cells,” Experimental Diabetes Research, vol. 2012, Article ID 518426, 11 pages, 2012.
- W. D. Thompson, W. W. Li, and M. Maragoudakis, “The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies,” The Journal of Pathology, vol. 190, no. 3, pp. 330–337, 2000.
- J. M. Isner and T. Asahara, “Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization,” Journal of Clinical Investigation, vol. 103, no. 9, pp. 1231–1236, 1999.
- S. Patel-Hett and P. A. D'Amore, “Signal transduction in vasculogenesis and developmental angiogenesis,” International Journal of Developmental Biology, vol. 55, no. 4-5, pp. 353–369, 2011.
- P. H. Huang, Y. H. Chen, H. Y. Tsai et al., “Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 4, pp. 869–877, 2010.
- J. Lu, V. J. Pompili, and H. Das, “Neovascularization and hematopoietic stem cells,” Cell Biochemistry and Biophysics. In press.
- M. B. Grant, W. S. May, S. Caballero et al., “Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization,” Nature Medicine, vol. 8, no. 6, pp. 607–612, 2002.
- S. Rafii and D. Lyden, “Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration,” Nature Medicine, vol. 9, no. 6, pp. 702–712, 2003.
- I. Rajantie, M. Ilmonen, A. Alminaite, U. Ozerdem, K. Alitalo, and P. Salven, “Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells,” Blood, vol. 104, no. 7, pp. 2084–2086, 2004.
- B. A. Peters, L. A. Diaz, K. Polyak et al., “Contribution of bone marrow-derived endothelial cells to human tumor vasculature,” Nature Medicine, vol. 11, no. 3, pp. 261–262, 2005.
- C. Napoli, T. Hayashi, F. Cacciatore et al., “Endothelial progenitor cells as therapeutic agents in the microcirculation: an update,” Atherosclerosis, vol. 215, no. 1, pp. 9–22, 2011.
- J. Rehman, J. Li, C. M. Orschell, and K. L. March, “Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors,” Circulation, vol. 107, no. 8, pp. 1164–1169, 2003.
- T. Ziegelhoeffer, B. Fernandez, S. Kostin et al., “Bone marrow-derived cells do not incorporate into the adult growing vasculature,” Circulation Research, vol. 94, no. 2, pp. 230–238, 2004.
- C. Urbich, A. Aicher, C. Heeschen et al., “Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells,” Journal of Molecular and Cellular Cardiology, vol. 39, no. 5, pp. 733–742, 2005.
- J. Hur, C. H. Yoon, H. S. Kim et al., “Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 2, pp. 288–293, 2004.
- Y. H. Chen, S. J. Lin, F. Y. Lin et al., “High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms,” Diabetes, vol. 56, no. 6, pp. 1559–1568, 2007.
- T. Asahara, H. Masuda, T. Takahashi et al., “Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization,” Circulation Research, vol. 85, no. 3, pp. 221–228, 1999.
- M. Ii, H. Nishimura, A. Iwakura et al., “Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via “imported” nitric oxide synthase activity,” Circulation, vol. 111, no. 9, pp. 1114–1120, 2005.
- S. M. Bauer, L. J. Goldstein, R. J. Bauer, H. Chen, M. Putt, and O. C. Velazquez, “The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia,” Journal of Vascular Surgery, vol. 43, no. 1, pp. 134–141, 2006.
- H. Masuda, C. Kalka, T. Takahashi et al., “Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis,” Circulation Research, vol. 101, no. 6, pp. 598–606, 2007.
- T. Murayama, O. M. Tepper, M. Silver et al., “Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo,” Experimental Hematology, vol. 30, no. 8, pp. 967–972, 2002.
- N. I. Moldovan and T. Asahara, “Role of blood mononuclear cells in recanalization and vascularization of thrombi: past, present, and future,” Trends in Cardiovascular Medicine, vol. 13, no. 7, pp. 265–269, 2003.
- J. Folkman and Y. Shing, “Angiogenesis,” Journal of Biological Chemistry, vol. 267, no. 16, pp. 10931–10934, 1992.
- K. Jujo, M. Ii, and D. W. Losordo, “Endothelial progenitor cells in neovascularization of infarcted myocardium,” Journal of Molecular and Cellular Cardiology, vol. 45, no. 4, pp. 530–544, 2008.
- T. Asahara, A. Kawamoto, and H. Masuda, “Concise review: circulating endothelial progenitor cells for vascular medicine,” Stem Cells, vol. 29, no. 11, pp. 1650–1655, 2011.
- S. Arnhold, P. Heiduschka, H. Klein et al., “Adenovirally transduced bone marrow stromal cells differentiate into pigment epithelial cells and induce rescue effects in RCS rats,” Investigative Ophthalmology and Visual Science, vol. 47, no. 9, pp. 4121–4129, 2006.
- M. O. Karl and T. A. Reh, “Regenerative medicine for retinal diseases: activating endogenous repair mechanisms,” Trends in Molecular Medicine, vol. 16, no. 4, pp. 193–202, 2010.
- F. Gaillard and Y. Sauvé, “Cell-based therapy for retina degeneration: the promise of a cure,” Vision Research, vol. 47, no. 22, pp. 2815–2824, 2007.
- M. Caputo, H. Zirpoli, R. Di Benedetto, K. De Nadai, and M. F. Tecce, “Perspectives of choroidal neovascularization therapy,” Current Drug Targets, vol. 12, no. 2, pp. 234–242, 2011.
- T. Chan-Ling, J. E. Dahlstrom, M. E. Koina et al., “Evidence of hematopoietic differentiation, vasculogenesis and angiogenesis in the formation of human choroidal blood vessels,” Experimental Eye Research, vol. 92, no. 5, pp. 361–376, 2011.
- H. Y. Hou, H. L. Liang, Y. S. Wang et al., “A therapeutic strategy for choroidal neovascularization based on recruitment of mesenchymal stem cells to the sites of lesions,” Molecular Therapy, vol. 18, no. 10, pp. 1837–1845, 2010.
- A. De Marzo, C. Aruta, and V. Marigo, “PEDF promotes retinal neurosphere formation and expansion in vitro,” Advances in Experimental Medicine and Biology, vol. 664, pp. 621–630, 2010.
- C. Aruta, F. Giordano, A. De Marzo et al., “In vitro differentiation of retinal pigment epithelium from adult retinal stem cells,” Pigment Cell and Melanoma Research, vol. 24, no. 1, pp. 233–240, 2011.
- D. Zhu, X. Deng, C. Spee et al., “Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival,” Investigative Ophthalmology and Visual Science, vol. 52, no. 3, pp. 1573–1585, 2011.
- H. Vaajasaari, T. Ilmarinen, K. Juuti-Uusitalo et al., “Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells,” Molecular Vision, vol. 17, pp. 558–575, 2011.
- S. I. Yamagishi, T. Matsui, K. Nakamura, S. Ueda, Y. Noda, and T. Imaizumi, “Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications,” Current drug targets, vol. 9, no. 11, pp. 1025–1029, 2008.
- C. H. Chang, C. S. Tsai, Y. F. Jim, H. C. Wu, C. C. Lin, and A. Kao, “Lumbar bone mineral density in prostate cancer patients with bone metastases,” Endocrine Research, vol. 29, no. 2, pp. 177–182, 2003.
- Y. Zhao, Q. Bao, A. Renner et al., “Cancer stem cells and angiogenesis,” International Journal of Developmental Biology, vol. 55, no. 4-5, pp. 477–482, 2011.
- X. H. Yao, Y. F. Ping, and X. W. Bian, “Contribution of cancer stem cells to tumor vasculogenic mimicry,” Protein and Cell, vol. 2, no. 4, pp. 266–272, 2011.
- W. Fan, R. Crawford, and Y. Xiao, “The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization,” Differentiation, vol. 81, no. 3, pp. 181–191, 2011.
- K. B. Manalo, P. F. Choong, and C. R. Dass, “Pigment epithelium-derived factor as an impending therapeutic agent against vascular epithelial growth factor-driven tumor-angiogenesis,” Molecular Carcinogenesis, vol. 50, no. 2, pp. 67–72, 2011.
- L. Elzaouk, K. Moelling, and J. Pavlovic, “Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model,” Experimental Dermatology, vol. 15, no. 11, pp. 865–874, 2006.
- P. Gao, Q. Ding, Z. Wu, H. Jiang, and Z. Fang, “Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma,” Cancer Letters, vol. 290, no. 2, pp. 157–166, 2010.
- D. P. Fitzgerald, P. Subramanian, M. Deshpande, et al., “Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage,” Cancer Research, vol. 72, no. 1, pp. 144–153, 2012.
- Y. Gao, A. Yao, W. Zhang et al., “Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice,” Oncogene, vol. 29, no. 19, pp. 2784–2794, 2010.
- Y. F. Ping and X. W. Bian, “Consice review: contribution of cancer stem cells to neovascularization,” Stem Cells, vol. 29, no. 6, pp. 888–894, 2011.
- L. Z. Zhang, C. Q. Zhang, Z. Y. Yan, Q. C. Yang, Y. Jiang, and B. F. Zeng, “Tumor-initiating cells and tumor vascularization,” Pediatric Blood and Cancer, vol. 56, no. 3, pp. 335–340, 2011.
- J. W. Chen, Y. H. Chen, and S. J. Lin, “Long-term exposure to oxidized low-density lipoprotein enhances tumor necrosis factor-α-stimulated endothelial adhesiveness of monocytes by activating superoxide generation and redox-sensitive pathways,” Free Radical Biology and Medicine, vol. 40, no. 5, pp. 817–826, 2006.
- C. S. Tsai, F. Y. Lin, Y. H. Chen et al., “Cilostazol attenuates MCP-1 and MMP-9 expression in vivo in LPS-administrated balloon-injured rabbit aorta and in vitro in LPS-treated monocytic THP-1 cells,” Journal of Cellular Biochemistry, vol. 103, no. 1, pp. 54–66, 2008.
- Y. H. Chen, S. J. Lin, Y. L. Chen, P. L. Liu, and J. W. Chen, “Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules,” Cardiovascular and Hematological Disorders, vol. 6, no. 4, pp. 279–304, 2006.
- C. H. Wu, B. R. Tsai, W. T. Hsieh, G. Y. Chang, S. J. T. Mao, and W. C. Chang, “The preventive effects of G115 on balloon injury-induced neointima formation in rats,” Life Sciences, vol. 70, no. 6, pp. 669–679, 2001.
- H. C. Huang, G. Y. Shi, S. J. Jiang et al., “Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain,” Journal of Biological Chemistry, vol. 278, no. 47, pp. 46750–46759, 2003.
- M. Peichev, A. J. Naiyer, D. Pereira et al., “Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors,” Blood, vol. 95, no. 3, pp. 952–958, 2000.
- R. K. Burt, Y. Loh, W. Pearce et al., “Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases,” Journal of the American Medical Association, vol. 299, no. 8, pp. 925–936, 2008.
- E. Crimi, L. J. Ignarro, and C. Napoli, “Microcirculation and oxidative stress,” Free Radical Research, vol. 41, no. 12, pp. 1364–1375, 2007.
- R. Karra, S. Vemullapalli, C. Dong et al., “Molecular evidence for arterial repair in atherosclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 46, pp. 16789–16794, 2005.
- C. Napoli, C. Maione, C. Schiano, C. Fiorito, and L. J. Ignarro, “Bone marrow cell-mediated cardiovascular repair: potential of combined therapies,” Trends in Molecular Medicine, vol. 13, no. 7, pp. 278–286, 2007.
- K. Nakamura, S. I. Yamagishi, T. Matsui et al., “Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation,” American Journal of Pathology, vol. 170, no. 6, pp. 2159–2170, 2007.
- S. I. Yamagishi, Y. Inagaki, K. Nakamura et al., “Pigment epithelium-derived factor inhibits TNF-α-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation,” Journal of Molecular and Cellular Cardiology, vol. 37, no. 2, pp. 497–506, 2004.
- S. T. Kao, C. C. Yeh, C. C. Hsieh et al., “The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest,” Life Sciences, vol. 69, no. 13, pp. 1485–1496, 2001.
- S. H. Fang, Y. C. Hou, W. C. Chang, S. L. Hsiu, P. D. L. Chao, and B. L. Chiang, “Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock,” Life Sciences, vol. 74, no. 6, pp. 743–756, 2003.
- H. Liang, H. Hou, W. Yi, et al., “Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury,” European Heart Journal. In press.
- N. L. Ward and J. C. LaManna, “The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems,” Neurological Research, vol. 26, no. 8, pp. 870–883, 2004.
- Q. Shen, S. K. Goderie, L. Jin et al., “Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells,” Science, vol. 304, no. 5675, pp. 1338–1340, 2004.
- K. Pumiglia and S. Temple, “PEDF: bridging neurovascular interactions in the stem cell niche,” Nature Neuroscience, vol. 9, no. 3, pp. 299–300, 2006.
- C. Ramírez-Castillejo, F. Sánchez-Sánchez, C. Andreu-Agulló et al., “Pigment epithelium-derived factor is a niche signal for neural stem cell renewal,” Nature Neuroscience, vol. 9, no. 3, pp. 331–339, 2006.
- D. Palmieri, J. M. Watson, and C. A. Rinehart, “Age-related expression of PEDF/EPC-1 in human endometrial stromal fibroblasts: implications for interactive senescence,” Experimental Cell Research, vol. 247, no. 1, pp. 142–147, 1999.
- M. Tavazoie, L. Van der Veken, V. Silva-Vargas et al., “A specialized vascular niche for adult neural stem cells,” Cell Stem Cell, vol. 3, no. 3, pp. 279–288, 2008.
- Q. Shen, Y. Wang, E. Kokovay et al., “Adult SVZ stem cells lie in a vascular Niche: a quantitative analysis of Niche cell-cell interactions,” Cell Stem Cell, vol. 3, no. 3, pp. 289–300, 2008.
- C. Andreu-Agullo, J. M. Morante-Redolat, A. C. Delgado, et al., “Vascular niche factor PEDF modulates notch-dependent stemness in the adult subependymal zone,” Nature Neuroscience, vol. 12, no. 12, pp. 1514–1523, 2009.
- S. Filleur, T. Nelius, W. De Riese, and R. C. Kennedy, “Characterization of pedf: a multi-functional serpin family protein,” Journal of Cellular Biochemistry, vol. 106, no. 5, pp. 769–775, 2009.